Non-small cell lung cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Voluntary participation and signing of the informed consent form; 2. Age 18 to 80 years old, gender unrestricted; 3. American Society of Anesthesiologists (ASA) classification I-III; 4. Patients scheduled to undergo video-assisted thoracoscopic surgery.
Exclusion criteria
Exclusion criteria: 1. Patients who refuse surgery and/or anesthesia plans; 2. Patients with any severe or uncontrollable systemic diseases, such as: 1) Major and symptomatic severe arrhythmias, conduction abnormalities or morphological abnormalities on resting electrocardiogram that are difficult to control, such as second-degree or higher atrioventricular block, ventricular arrhythmias or atrial fibrillation; 2) Unstable angina pectoris, congestive heart failure, chronic heart failure with New York Heart Association (NYHA) classification > grade 2; 3) Any arterial thrombosis, embolism or ischemia within 6 months before enrollment in the treatment, such as myocardial infarction, cerebrovascular accident or transient ischemic attack, etc.; 4) A history of non-infectious pneumonia requiring glucocorticoid treatment within 1 year before the first administration, or current clinical active interstitial lung disease; 5) Active pulmonary tuberculosis; 6) Active or uncontrolled infections requiring systemic treatment; 7) Active diverticulitis, abdominal abscess, gastrointestinal obstruction; 8) Liver diseases such as liver cirrhosis, decompensated liver disease, acute or chronic active hepatitis; 9) Urine routine test shows urine protein =++, and confirmed 24-hour urine protein quantification > 1.0 g; 10) Patients with mental disorders and inability to cooperate with treatment; 3. Phrenic nerve palsy on the non-surgical side; 4. Medical history or evidence of disease, treatment or laboratory abnormalities that may interfere with the results of the trial, prevent the participant from participating in the study fully, or other conditions considered by the investigator to be unsuitable for enrollment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of lens cleanings;Lens cleaning time; | — |
Secondary
| Measure | Time frame |
|---|---|
| Single lens cleaning time;Re-cleaning rate of lens;Operation time;Anesthesia time;Postoperative pulmonary complications;The percentage of neutrophilic granulocyte,IL-6,IFN,TNF; | — |
Countries
China
Contacts
the Affiliated Hospital of Qingdao University